Research peptides studied for focus, memory, and neuroprotection.
What the research says about Dihexa, angiotensin IV analog, HGF/c-Met signaling, preclinical neurogenesis data, the absence of human trials, and FDA April 15, 2026 transitional regulatory status.
Read articleWhat the research says about Selank, anxiolytic properties, GABA and BDNF modulation, cognitive research, side effects, and FDA Category 2 legal status.
What the research says about Semax, BDNF stimulation, neuroprotective properties, cognitive research, side effects, and FDA Category 2 legal status.
Ready when you are
Take a 3-minute assessment and a licensed clinician will recommend the right protocol for you — compounded in the USA by licensed 503A pharmacies.